Prot #A35-009: A Phase 3 Study of Safety and Efficacy of AMX0035 in Progressive Supranuclear Palsy (ORION)

Project: Research project

Project Details

StatusActive
Effective start/end date6/21/24 → 6/21/27

Funding

  • Quintiles, Inc. (Prot #A35-009 AMD 1 // Prot #A35-009 AMD 1)
  • Amylyx Pharmaceuticals, Inc. (Prot #A35-009 AMD 1 // Prot #A35-009 AMD 1)